More research is needed, but the findings suggest that semaglutide and, perhaps other GLP-1 agonists, hold promise for helping people with MASH and highlight yet another potential benefit from this type of drug
[PubMed Central ID: PMC4985186]
Adems, cuestiona aspectos metodolgicos del estudio, al advertir un alto riesgo de sesgo de seleccin y sostiene que se limita la evaluacin de si las personas estuvieron expuestas a semaglutida cuando ocurri el evento
By focusing on high-quality protein, consistent hydration, and nutrient support like our GLP-1 Daily Support supplement, you can help your body bridge the energy gap
GLP-1RAs Are Uniquely Compelling for Addiction Treatment and Prevention I started prescribing it for this use about a year and a half ago, so far I've prescribed it to maybe a dozen patients just for this reason